# Correction: Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers

**Authors:** Bowen Sun, Seth Mason, Robert C. Wilson, Starr E. Hazard, Yubao Wang, Rong Fang, Qiwei Wang, Elizabeth S. Yeh, Meixiang Yang, Thomas M. Roberts, Jean J. Zhao, Qi Wang

PMC · DOI: 10.1038/s41388-024-02999-1 · 2024-05-29

## Full-text entities

- **Genes:** CDK7 (cyclin dependent kinase 7) [NCBI Gene 1022] {aka CAK, CAK1, CDKN7, HCAK, MO15, STK1}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}
- **Diseases:** breast cancers (MESH:D001943)

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11178485/full.md

---
Source: https://tomesphere.com/paper/PMC11178485